awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47304122-9DC31AB7-E95D-4E0A-8C8D-742E4E47DA9B
Q47304122-9DC31AB7-E95D-4E0A-8C8D-742E4E47DA9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47304122-9DC31AB7-E95D-4E0A-8C8D-742E4E47DA9B
Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology.
P2860
Q47304122-9DC31AB7-E95D-4E0A-8C8D-742E4E47DA9B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47304122-9DC31AB7-E95D-4E0A-8C8D-742E4E47DA9B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4073ae625354e45db987928e3771c94c29c7ac2
P2860
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A